Open AccessESBL, MBL and Ampc Lactamases Producing Superbugs – Havoc in the Intensive Care Units of Punjab India
Author(s) -
Loveena Oberoi
Publication year - 2013
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2012/5016.2673
Subject(s) - antibiotic resistance , microbiology and biotechnology , klebsiella pneumonia , multiple drug resistance , antibiotics , intensive care , antimicrobial , escherichia coli , biology , drug resistance , medicine , intensive care medicine , biochemistry , gene
An alarming rise in the rates of the antibiotic resistance has now become a serious and an increasingly common public health concern, with severe implications, especially in the intensive care units. A variety of β-lactamases which include ESBLs, AmpC β-lactamases and metallo-βlactamases, have emerged as the most worrisome mechanism of resistance among the gram negative bacteria, which pose a therapeutic challenge to the health care settings.